|Articles|January 27, 2022
The Underrecognized Burden of Atopic Dermatitis in the United States
Advertisement
This publication is sponsored by AbbVie Inc.
This Clinical Brief provides an overview of the complex pathogenesis, heavy burden, and limited diagnostic, staging, and therapeutic options available for more severe atopic dermatitis.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5